Nuvation Bio (NUVB) Acquisitions (2024)
Nuvation Bio (NUVB) posted quarterly Acquisitions of -$1000.0 for Q4 2024.
Powered by 
Analysis
Nuvation Bio (NUVB) Acquisitions (2024) Analysis & Trends
Nuvation Bio (NUVB) has reported Acquisitions for 1 consecutive years, with -$1000.0 the latest figure, recorded in Q4 2024.
- In Q4 2024, Acquisitions changed N/A year-over-year to -$1000.0; the TTM figure through Dec 2025 stood at -$1000.0 (changed 0.0% YoY), while the FY2024 annual figure was $19.9 million, changed N/A from the prior year.
- Acquisitions held at -$1000.0 in Q4 2024 per NUVB's latest filing.
- Across five years, Acquisitions topped out at -$1000.0 in Q4 2024 and bottomed at -$1000.0 in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Nuvation Bio | 2.38 Bn | 2.38 Bn | 30.78 Mn | - |